# Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

> **NCT03592004** · — · UNKNOWN · sponsor: **Chinese Academy of Sciences** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer
- Radiomics
- Neoadjuvant Chemotherapy
- Multi-parametric MRI

## Interventions

- **OTHER:** neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT03592004
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-18
- **Primary completion:** 2019-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2018-07-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592004, "Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03592004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*